Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/17 → 8/31/18 |
Funding
- Gilead Sciences Inc: $21,918.00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis GS-US-384-1943
- Grigorian, Alla (PI)